DOD FY11 Lung Cancer Investigator-Initiated Translational Research Award
The summary for the DOD FY11 Lung Cancer Investigator-Initiated Translational Research Award Federal Grant is detailed below.
It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section.
If these sections are incomplete, please visit the website of the government agency that is offering this grant.
Federal Grant Title:
DOD FY11 LUNG CANCER INVESTIGATOR-INITIATED TRANSLATIONAL RESEARCH AWARD
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility
Information not provided
The Lung Cancer Research Program Investigator-Initiated Translational Research Award supports translational research that will accelerate the movement of promising ideas in lung cancer into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. Observations that drive a research idea may be derived from a laboratory discovery, population-based studies, or a clinicians firsthand knowledge of patients and anecdotal data. While the ultimate goal of translational research is to move an observation forward into the clinical application, Principal Investigators (PIs) should not view translational research as a one-way continuum from bench to bedside.